SCPHARMACEUTICALS INC. - COMMON STOCK

scPharmaceuticals Inc. Announces FDA Acceptance of FUROSCIX® New Drug Application

16 May 2022 06:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Announces Resubmission of FUROSCIX® New Drug Application

11 Apr 2022 06:00:00 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

22 Mar 2022 06:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals to Present at the 42nd Annual Cowen Healthcare Conference

16 Feb 2022 15:05:00 By Nasdaq GlobeNewswire

scPharmaceuticals to Present at the 11th Annual SVB Leerink Global Healthcare Conference

03 Feb 2022 07:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals to Participate in Two Upcoming Investor Conferences

20 Dec 2021 15:05:00 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update

09 Nov 2021 06:00:02 By Nasdaq GlobeNewswire

scPharmaceuticals to Present at the Jefferies London Healthcare Conference

02 Nov 2021 07:30:01 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Presents Late-breaking FREEDOM-HF Study Data at the Heart Failure Society of America Annual Scientific Meeting 2021

10 Sep 2021 07:00:00 By Nasdaq GlobeNewswire

scPharmaceuticals to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference

01 Sep 2021 07:00:02 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Second Quarter 2021 Financial Results and Provides Business Update

11 Aug 2021 06:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Announces Positive Top-Line Results from FREEDOM-HF Study

13 Jul 2021 15:08:26 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Announces Receipt of Written Minutes from Type C Meeting with the FDA Regarding Development of FUROSCIX®

01 Jul 2021 07:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

19 May 2021 07:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports First Quarter 2021 Financial Results and Provides Business Update

12 May 2021 07:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

23 Mar 2021 06:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals to Present in Two Upcoming Investor Conferences

25 Feb 2021 07:00:02 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Announces Results of Type A End-of-Review Meeting with FDA Regarding FUROSCIX® NDA

23 Feb 2021 07:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals Inc. Appoints Renowned Heart Failure Specialist William T. Abraham, M.D., to its Board of Directors

17 Feb 2021 07:00:01 By Nasdaq GlobeNewswire

scPharmaceuticals to Present at the 10th Annual SVB Leerink Global Healthcare Conference

11 Feb 2021 07:00:01 By Nasdaq GlobeNewswire